Johan F. Paulsson
Novo Nordisk Research Park
Maaloev, 2760, Denmark
Maaloev, 2760, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Variant screening of PYY3-36 leads to potent long-acting PYY analogs with superior Y2 receptor selectivity.
Journal: Science translational medicine
Published: March 26, 2025
Rational Development of Stable PYY3-36 Peptide Y2 Receptor Agonists.
Journal: Pharmaceutical research
Published: March 15, 2021
The Design of a GLP-1/PYY Dual Acting Agonist.
Journal: Angewandte Chemie (International ed. in English)
Published: December 11, 2020
Kisspeptin-52 partially rescues the activity of the hypothalamus-pituitary-gonadal axis in underweight male rats dosed with an anti-obesity compound.
Journal: Toxicology and applied pharmacology
Published: May 20, 2020
UCP1-independent glucose-lowering effect of leptin in type 1 diabetes: only in conditions of hypoleptinemia.
Journal: American journal of physiology. Endocrinology and metabolism
Published: November 20, 2019
Cellular clearance of circulating transthyretin decreases cell-nonautonomous proteotoxicity in Caenorhabditis elegans.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 01, 2018
Elucidation of the Binding Mode of the Carboxyterminal Region of Peptide YY to the Human Y2 Receptor.
Journal: Molecular pharmacology
Published: September 12, 2017
In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease.
Journal: The American journal of pathology
Published: August 02, 2014
Design and Synthesis of Peptide YY Analogues with C-terminal Backbone Amide-to-Ester Modifications.
Journal: ACS medicinal chemistry letters
Published: August 30, 2013
A parallel semisynthetic approach for structure-activity relationship studies of peptide YY.
Journal: ChemMedChem
Published: July 01, 2013
Last Updated: 09/26/2026